Table 3.
Association of PNI with clinical features of cervical cancer patients.
| Variable | PNI (High) | PNI (Low) | X2 | P |
|---|---|---|---|---|
| Age (year) | ||||
| <50 | 49 (62.00%) | 12 (38.70%) | 4.89 | 0.027 |
| ≥50 | 30 (38.0%) | 19 (61.3%) | ||
| FIGO stage | ||||
| I + II | 40 (50.60%) | 12 (38.80%) | 4.01 | 0.26 |
| III + IV | 39 (49.40%) | 19 (61.20%) | ||
| Histological type | ||||
| SCC | 72 (91.10%) | 25 (80.60%) | 2.35 | 0.125 |
| Non-SCC | 7 (8.90%) | 6 (19.40%) | ||
| Lymph node metastasis | ||||
| Negative | 44 (55.70%) | 13 (41.90%) | 1.69 | 0.194 |
| Positive | 35 (44.30%) | 18 (58.10%) | ||
| Maximum tumour size (cm) | ||||
| >4 cm | 48 (60.80%) | 17 (54.80%) | 0.32 | 0.57 |
| ≤4 cm | 31 (39.20%) | 14 (45.20%) | ||
| Prognosis | ||||
| Effective | 59 (74.70%) | 14 (45.20%) | 6.15 | 0.013 |
| Ineffective | 20 (25.30%) | 17 (54.80%) |
PNI, prognostic nutritional index; FIGO, International Federation of Gynaecology and Obstetrics; SCC, squamous cell carcinoma.